If you or a loved one suffered serious side effects after DePuy hip replacement surgery, you have company.
Thousands of patients in the United States and beyond claim to have been seriously hurt by DePuy products, such as the metal-on-metal ASR XL Acetabular system.
Unfortunately, most information about the DePuy legal actions comes in the context of some sort of advocacy. No doubt, you’ve found dozens of law firms that “specialize” in hip replacement lawsuits. Meanwhile, Johnson & Johnson, the company that owns DePuy Orthopedics, Inc., offers its own seemingly articulate and convincing take.
In today’s blog post and in a subsequent one later this week, we’ll try to describe the gist of the DuPuy controversy in plain language and give you tools and resources to make progress with your case. Of course, the Law Offices of Michael A. DeMayo does specialize in hip replacement lawsuits, so we can’t claim to be neutral observers. However, our goal, above all else, is to ensure that injured victims gain clarity and peace of mind. Even if you choose another firm to represent you — or decide to take no legal action at all — we hope these articles will prove valuable to you.
Given that prelude, let’s touch on the basics of the hip replacement controversy. In our follow up post on Thursday, we’ll dive deeper into common issues claimants like you face.
In 2005, J&J obtained special permission from the FDA to market the DePuy ASR XL Acetabular system. They got this permission without running the product through a full gamut of tests. Within three years, over 400 people complained to the FDA about problems with these products. By early 2010, even Johnson & Johnson accepted that ASR hip replacements failed astonishingly often — approximately one out of eight recipients needs revisionary surgery. By the fall of 2010, DePuy voluntarily recalled two ASR devices. But the damage had been done. Many neutral industry watchers chided DePuy for waiting over 18 months before enacting the recall.
What did DePuy finally change course? A study examining five year failure data on the equipment found a 12%-13% failure rate — that’s woefully high.
Common side effects reported included bone fracture, pain, misalignment of joints, damage to soft tissue, and the release of potentially toxic metal compounds into the blood stream, which in turn damaged nerves, caused swelling and inflammation, stained the bone, and led to necrosis.
All told, nearly 100,000 people around the world have received ASR implants. Injured patients have lobbed hundreds of lawsuits against DePut to collect money for suffering, pain, costs of additional surgery, and other damages.
If you would like immediate assistance with your case, connect with the DeMayo Law team today, and stay tuned for our next blog post, which will address some less technical, but no less compelling, questions about these lawsuits.